TP53 and colorectal carcinoma: As described before, the majority of TRIMs functionally implied in the pathogenesis of CRC (e.g., TRIM23, TRIM24, TRIM25, TRIM28, and TRIM29) promote p53 degradation pathways either directly, or through increasing the activity of the E3 ligase Mdm2.